SCHEMBL29920559

SCHEMBL29920559

CCn1c2ccccc2c2cc(Nc3ccnc(Nc4c(OC)cc(OC)cc4OC)n3)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAC1 P63000 1/20 0.55
▸ MAPT P10636 11/20 0.48
▸ KDM4E B2RXH2 8/20 0.48
▸ HPGD P15428 7/20 0.48
▸ LMNA P02545 6/20 0.48
▸ ALDH1A1 P00352 6/20 0.48
▸ SMN1; SMN2 Q16637 5/20 0.48
▸ RAB9A P51151 4/20 0.48
▸ HCRTR1 O43613 3/20 0.48
▸ PAX8 Q06710 1/20 0.48
▸ IGF1R P08069 4/20 0.48
▸ EGFR P00533 1/20 0.47
▸ MEN1 O00255 5/20 0.45
▸ KMT2A Q03164 5/20 0.45
▸ HTT P42858 3/20 0.45
▸ POLB P06746 3/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ MAPK1 P28482 3/20 0.45
▸ MKNK2 Q9HBH9 1/20 0.45
▸ KDM1A O60341 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20966336 1.00 RAC1 (0.55) RAC1MAPTKDM4EHPGDLMNA
SCHEMBL29920671 0.86 RAC1 (0.59) RAC1MAPTKDM4EHPGDLMNA
SCHEMBL20966311 0.86 RAC1 (0.59) RAC1MAPTKDM4EHPGDLMNA
SCHEMBL20966330 0.80 RAC1 (0.67) RAC1MAPTKDM4EHPGDLMNA
SCHEMBL20945473 0.78 RAC1 (0.69) RAC1MAPTKDM4EHPGDLMNA
SCHEMBL15064233 0.77 RAC1 (0.57) RAC1MAPTKDM4EHPGDLMNA
SCHEMBL20945449 0.77 NTRK1 (0.53) RAC1MAPTKDM4EHPGDLMNA
SCHEMBL20945431 0.76 PDE10A (0.41) MAPTKDM4EHPGDLMNAALDH1A1
SCHEMBL20945474 0.75 RAC1 (0.63) RAC1MAPTKDM4EHPGDLMNA
SCHEMBL25186625 0.74 MAPT (0.66) MAPTKDM4EHPGDLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2022-09-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents CDC42, ARHGEF2, HRAS RAC1 7/4885MAPT 3790/4885KDM4E 3473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback